Pediatria Polska

Abstract

3/2022 vol. 97
Case report

Mycophenolate mofetil-related colitis in a paediatric patient after kidney transplant

  1. Students’ Association, Medical University of Silesia, Katowice, Poland
  2. Department of Paediatrics, Faculty of Medical Sciences in Zabrze, Students’ Association, Medical University of Silesia, Katowice, Poland
  3. Department of Nephrology, Kidney Transplantation and Hypertension, the Children’s Memorial Health Institute, Warsaw, Poland
Pediatr Pol 2022; 97 (3): 260-263
Online publish date: 2022/10/18
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
Mycophenolate mofetil (MMF) is an immunosuppressive agent, the gastrointestinal side effects of which include abdominal pain, diarrhoea, and vomiting. MMF may also cause symptomatic colitis, although it is a rare condition. We present herein the case of a boy with chronic kidney disease, lasting since the neonatal period, and caused by WT1 gene mutation. The patient developed colitis during an immunosuppressive therapy applied after a kidney transplant. Histopathology of intestinal biopsy specimens revealed features of MMF-related colitis. A modification of the immunosuppressive treatment and the implementation of a nutritional programme to the patient resulted in the disappearance of clinical signs and helped in a gradual body weight gain.
Share
without publication fees
without publication fees